Prakiraan pendapatan perusahaan: Coherus (CHRS)

Coherus Biosciences (CHRS) - logo korporat

Coherus Biosciences (CHRS) relies on diversified manufacturing and a warehouse network in the US. The company's sales target reflects market revenue expectations, where 0.05 becomes the new value for this metric. The business is expanding through biosimilars and depends on insurance coverage, yet faces aggressive dumping and patent disputes within the oncology segment.

Volume dodolan sing dikarepake perusahaan: Coherus Biosciences (CHRS) kanggo 04.07.2022 - 18.11.2026

Ringkesan rincian data analitis Coherus Biosciences (CHRS)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:Coherus Biosciences CHRS
Sampel barang Coherus BioSciences, Inc

This indicator assesses long-term revenue potential by filtering out short-term volatility through the aggregation of forecast data to identify a sustainable business scaling trend. By analyzing the expected sales volume of Coherus Biosciences (CHRS), investors can observe a smoothed expansion trajectory, which, in the case of Coherus Biosciences, depends directly on the market penetration of LOQTORZI and the commercial success of its biosimilar pipeline.

Pesaing wigati

Prakiraan pendapatan perusahaan Incyte Pharma (INCY)|Prakiraan pendapatan perusahaan HCM (Hutchison MediPharma)|Prakiraan pendapatan perusahaan Nuvation Pharma NUVB|Day One Biopharmaceuticals Inc - Prakiraan pendapatan perusahaan|MNPR - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Inhibrx Biosciences|IMAB: Prakiraan volume dodolan|Prakiraan dodolan perusahaan Fennec Pharmaceuticals Inc FENC|Volume dodolan mangsa ngarep perusahaan HRTX|Volume dodolan sing dikarepake perusahaan Nuvectis Pharma, Inc. NVCT|Volume dodolan mangsa ngarep perusahaan CRBP (Corbus Pharmaceuticals)|CRDF (Cardiff Oncology Corp) - Pendapatan mangsa ngarep perusahaan|BeyondSpring Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan BCAB (BioAtla Corp)|Lixte Biotechnology Holdings - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan CTXR (citiuspharma.com)|CLRB: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolinerx.com (BLRX)|Prakiraan pendapatan perusahaan Can-Fite BioPharma Ltd.|APRE: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan KZIA|Prakiraan volume dodolan Silexion Therapeutics Corp. (SLXN)|Prakiraan pendapatan perusahaan NuCana PLC NCNA|CMRX (Chimerix) - Pendapatan sing dikarepake perusahaan|CYCC: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan g1therapeutics.com|Kronos Bio Inc (KRON) - Prakiraan pendapatan perusahaan|Kintara (KTRA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Oncternal Therapeutics, Inc.|Volume dodolan sing dikarepake perusahaan portagebiotech.com PRTG